Exact Sciences Corp (EXAS)
53.00
-1.15
(-2.12%)
USD |
NASDAQ |
May 10, 13:38
Exact Sciences Research and Development Expense (Quarterly): 110.61M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 110.61M |
December 31, 2023 | 114.92M |
September 30, 2023 | 111.45M |
June 30, 2023 | 104.10M |
March 31, 2023 | 95.42M |
December 31, 2022 | 94.27M |
September 30, 2022 | 90.81M |
June 30, 2022 | 106.08M |
March 31, 2022 | 102.25M |
December 31, 2021 | 88.49M |
September 30, 2021 | 75.36M |
June 30, 2021 | 106.24M |
March 31, 2021 | 115.57M |
December 31, 2020 | 446.40M |
September 30, 2020 | 31.47M |
June 30, 2020 | 32.67M |
March 31, 2020 | 43.51M |
December 31, 2019 | 43.22M |
September 30, 2019 | 34.71M |
June 30, 2019 | 29.97M |
March 31, 2019 | 31.78M |
December 31, 2018 | 20.01M |
September 30, 2018 | 17.63M |
June 30, 2018 | 14.71M |
March 31, 2018 | 14.94M |
Date | Value |
---|---|
December 31, 2017 | 12.64M |
September 30, 2017 | 11.72M |
June 30, 2017 | 9.737M |
March 31, 2017 | 8.002M |
December 31, 2016 | 7.082M |
September 30, 2016 | 7.625M |
June 30, 2016 | 8.64M |
March 31, 2016 | 10.13M |
December 31, 2015 | 9.365M |
September 30, 2015 | 9.863M |
June 30, 2015 | 8.115M |
March 31, 2015 | 6.571M |
December 31, 2014 | 4.992M |
September 30, 2014 | 9.073M |
June 30, 2014 | 7.174M |
March 31, 2014 | 7.43M |
December 31, 2013 | 6.713M |
September 30, 2013 | 6.982M |
June 30, 2013 | 6.457M |
March 31, 2013 | 7.526M |
December 31, 2012 | 10.44M |
September 30, 2012 | 10.49M |
June 30, 2012 | 12.20M |
March 31, 2012 | 8.999M |
December 31, 2011 | 7.672M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
29.97M
Minimum
Jun 2019
446.40M
Maximum
Dec 2020
98.88M
Average
94.85M
Median
Research and Development Expense (Quarterly) Benchmarks
Illumina Inc | 339.00M |
Natera Inc | 82.96M |
Guardant Health Inc | 89.86M |
Quest Diagnostics Inc | -- |
Castle Biosciences Inc | 13.81M |